SCHEMBL4359098

SCHEMBL4359098

CC(=O)Nc1ccc(C[C@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)O)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.57
CTSL P07711 3/20 0.56
CTSS P25774 1/20 0.56
CTSK P43235 1/20 0.56
ACE P12821 2/20 0.55
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
PSMB5 P28074 2/20 0.54
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2D6 P10635 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
HDAC3 O15379 1/20 0.53
HDAC4 P56524 1/20 0.53
HDAC1 Q13547 1/20 0.53
HDAC7 Q8WUI4 1/20 0.53
HDAC2 Q92769 1/20 0.53
HDAC10 Q969S8 1/20 0.53
HDAC11 Q96DB2 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4358972 1.00 PTPN1 (0.57) PTPN1CTSLCTSSCTSKACE
SCHEMBL4363983 0.96 PTPN1 (0.58) PTPN1CTSLCTSSCTSKACE
SCHEMBL4361682 0.93 CTSL (0.56) PTPN1CTSLACECYP1A2CYP3A4
SCHEMBL4367283 0.93 CTSL (0.56) PTPN1CTSLACECYP1A2CYP3A4
SCHEMBL4363966 0.93 MMP9 (0.57) PTPN1CTSLCTSSCTSKMEN1
SCHEMBL4363527 0.93 CTSL (0.59) PTPN1CTSLCTSSCTSKMEN1
SCHEMBL4370929 0.90 GAA (0.57) CTSLCTSSCTSKMEN1KMT2A
SCHEMBL4359256 0.88 ACE (0.56) PTPN1CTSLCTSSCTSKACE
SCHEMBL4357736 0.87 ACE (0.68) PTPN1CTSLCTSSCTSKACE
SCHEMBL4356229 0.87 ACE (0.68) PTPN1CTSLCTSSCTSKACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247470-A1 PHENYLALANINE DIPEPTIDE DERIVATIVES, COMPOSITIONS AND USE THEREOF The Key Lab. Of Chemistry for Natural Products of Guizhou Province and Chinese Acad. of Sciences (CN) 2009-10-01 US claimed
US-9023809-B2 Phenylalanine dipeptide derivatives, compositions and use thereof THE KEY LABORATORY OF CHEMISTRY FOR NATURAL PRODUCTS OF GUIZHOU PROVINCE AND CHINESE ACADEMY OF SCIENCES (CN) 2015-05-05 US disclosed
US-20090247470-A1 PHENYLALANINE DIPEPTIDE DERIVATIVES, COMPOSITIONS AND USE THEREOF The Key Lab. Of Chemistry for Natural Products of Guizhou Province and Chinese Acad. of Sciences (CN) 2009-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247470-A1 PHENYLALANINE DIPEPTIDE DERIVATIVES, COMPOSITIONS AND USE THEREOF DNPEP, PEPD, VIP PTPN1 1817/4885CTSL 591/4885CTSS 3153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.